- Home
- BCBP vs MRSN Comparison
BCBP vs MRSN Comparison
Compare BCBP & MRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCBP
- MRSN
- Stock Information
- Founded
- BCBP 2000
- MRSN 2001
- Country
- BCBP United States
- MRSN United States
- Employees
- BCBP N/A
- MRSN N/A
- Industry
- BCBP Savings Institutions
- MRSN Biotechnology: Pharmaceutical Preparations
- Sector
- BCBP Finance
- MRSN Health Care
- Exchange
- BCBP Nasdaq
- MRSN Nasdaq
- Market Cap
- BCBP 201.8M
- MRSN 252.0M
- IPO Year
- BCBP N/A
- MRSN 2017
- Fundamental
- Price
- BCBP $13.50
- MRSN $2.04
- Analyst Decision
- BCBP Hold
- MRSN Buy
- Analyst Count
- BCBP 2
- MRSN 6
- Target Price
- BCBP $13.75
- MRSN $6.00
- AVG Volume (30 Days)
- BCBP 43.4K
- MRSN 1.3M
- Earning Date
- BCBP 10-18-2024
- MRSN 11-13-2024
- Dividend Yield
- BCBP 4.74%
- MRSN N/A
- EPS Growth
- BCBP N/A
- MRSN N/A
- EPS
- BCBP 1.17
- MRSN N/A
- Revenue
- BCBP $89,636,000.00
- MRSN $34,837,000.00
- Revenue This Year
- BCBP N/A
- MRSN N/A
- Revenue Next Year
- BCBP $6.99
- MRSN $7.15
- P/E Ratio
- BCBP $11.55
- MRSN N/A
- Revenue Growth
- BCBP N/A
- MRSN N/A
- 52 Week Low
- BCBP $9.19
- MRSN $1.22
- 52 Week High
- BCBP $13.90
- MRSN $6.28
- Technical
- Relative Strength Index (RSI)
- BCBP 64.52
- MRSN 46.80
- Support Level
- BCBP $12.77
- MRSN $1.98
- Resistance Level
- BCBP $13.65
- MRSN $2.35
- Average True Range (ATR)
- BCBP 0.29
- MRSN 0.28
- MACD
- BCBP 0.04
- MRSN -0.04
- Stochastic Oscillator
- BCBP 91.85
- MRSN 23.30
About BCBP BCB Bancorp Inc. (NJ)
BCB Bancorp Inc is a bank holding company. The company offers loans, including commercial and multi-family real estate loans, home equity loans, construction loans, consumer loans, and commercial business loans; FDIC-insured deposit products, such as savings and club accounts, interest and non-interest bearing demand accounts, money market accounts, certificates of deposit and individual retirement accounts, and retail and commercial banking services, including wire transfers, money orders, safe deposit boxes, a night depository, debit cards, online banking, gift cards, fraud detection, and automated teller services.
About MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company using its differentiated and proprietary ADC platforms to develop targeted drugs with increased tolerability and expanded opportunities to deliver meaningful clinical benefits to patients. The Company's early stage programs includes XMT-1660, a Dolasynthen ADC targeting B7-H4, as well as XMT-2056, a STING agonist ADC developed using the Company's Immunosynthen platform and targeting a novel epitope of human epidermal growth factor receptor 2. The Company also has two earlier stage preclinical candidates, XMT-2068 and XMT-2175, both of which leverage the Company's Immunosynthen platform and target tumor-associated antigens.